Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Race Oncology Ltd. ( (AU:RAC) ) has provided an announcement.
Race Oncology Ltd has announced the quotation of 941,090 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 25, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing development efforts in cancer therapeutics, potentially impacting its market positioning and providing opportunities for stakeholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapeutics. The company is primarily engaged in advancing its lead drug candidate, which targets specific cancer types, aiming to improve treatment outcomes for patients.
Average Trading Volume: 546,429
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$514.5M
Learn more about RAC stock on TipRanks’ Stock Analysis page.